These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 25706279

  • 1. Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation.
    Grabhorn E, Binder TM, Obrecht D, Brinkert F, Lehnhardt A, Herden U, Peine S, Nashan B, Ganschow R, Briem-Richter A.
    Transplantation; 2015 Sep; 99(9):1876-81. PubMed ID: 25706279
    [Abstract] [Full Text] [Related]

  • 2. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
    Süsal C, Wettstein D, Döhler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Živčić-Ćosić S, Balen S, Weimer R, Slavcev A, Bösmüller C, Norman DJ, Zeier M, Opelz G, Collaborative Transplant Study Report.
    Transplantation; 2015 Sep; 99(9):1976-80. PubMed ID: 25769065
    [Abstract] [Full Text] [Related]

  • 3. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, McDiarmid SV, Reed EF.
    Transplantation; 2015 Jul; 99(7):1416-22. PubMed ID: 26038872
    [Abstract] [Full Text] [Related]

  • 4. Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy.
    Schluckebier D, Cousin VL, Petit LM, Belli D, Wildhaber B, Rougemont AL, Villard J, Ferrari-Lacraz S, McLin VA.
    Pediatr Transplant; 2020 Feb; 24(1):e13611. PubMed ID: 31682057
    [Abstract] [Full Text] [Related]

  • 5. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
    Kubal C, Mangus R, Saxena R, Lobashevsky A, Higgins N, Fridell J, Tector AJ.
    Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
    [Abstract] [Full Text] [Related]

  • 6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Aug; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 7. Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation.
    Irving CA, Carter V, Gennery AR, Parry G, Griselli M, Hasan A, Kirk CR.
    J Heart Lung Transplant; 2015 Oct; 34(10):1310-7. PubMed ID: 26123951
    [Abstract] [Full Text] [Related]

  • 8. Post-transplant development of C1q-positive HLA antibodies and kidney graft survival.
    Piazza A, Poggi E, Ozzella G, Adorno D.
    Clin Transpl; 2013 Oct; ():367-75. PubMed ID: 25095531
    [Abstract] [Full Text] [Related]

  • 9. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 10. Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection.
    Touzot M, Couvrat-Desvergnes G, Castagnet S, Cesbron A, Renaudin K, Cantarovich D, Giral M.
    Transplantation; 2015 Jan; 99(1):63-8. PubMed ID: 25029384
    [Abstract] [Full Text] [Related]

  • 11. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
    Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P.
    Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
    [Abstract] [Full Text] [Related]

  • 12. Donor-specific antibodies after pediatric liver transplantation: a cross-sectional study of 50 patients.
    Kivelä JM, Kosola S, Peräsaari J, Mäkisalo H, Jalanko H, Holmberg C, Pakarinen MP, Lauronen J.
    Transpl Int; 2016 Apr; 29(4):494-505. PubMed ID: 26806435
    [Abstract] [Full Text] [Related]

  • 13. Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation.
    Couchonnal E, Rivet C, Ducreux S, Dumortier J, Bosch A, Boillot O, Collardeau-Frachon S, Dubois R, Hervieu V, André P, Scoazec JY, Lachaux A, Dubois V, Guillaud O.
    Transpl Immunol; 2017 Dec; 45():8-14. PubMed ID: 28782692
    [Abstract] [Full Text] [Related]

  • 14. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 15. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Iacob S, Cicinnati VR, Lindemann M, Heinemann FM, Radtke A, Kaiser GM, Kabar I, Schmidt HH, Baba HA, Beckebaum S.
    Transplantation; 2015 Sep 27; 99(9):1869-75. PubMed ID: 25706274
    [Abstract] [Full Text] [Related]

  • 16. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V, Venetz JP, Pantaleo G, Pascual M.
    Hum Immunol; 2009 Aug 27; 70(8):580-3. PubMed ID: 19375474
    [Abstract] [Full Text] [Related]

  • 17. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT, Silva MA, Murphy N, Briggs D, Mirza DF, Neil DA.
    Scand J Gastroenterol; 2013 Dec 27; 48(12):1444-51. PubMed ID: 24131305
    [Abstract] [Full Text] [Related]

  • 18. Novel biomarker combination predicts long-term allograft outcome.
    Cail J, Huang W, Terasaki PI, Everly MJ, Briley KP, Haisch CE, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Harland RC, Rebellato LM.
    Clin Transpl; 2013 Dec 27; ():319-24. PubMed ID: 25095524
    [Abstract] [Full Text] [Related]

  • 19. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 27; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 20. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    OʼLeary JG, Demetris AJ, Philippe A, Freeman R, Cai J, Heidecke H, Smith C, Hart B, Jennings LW, Catar R, Everly M, Klintmalm GB, Dragun D.
    Transplantation; 2017 Oct 27; 101(10):2399-2409. PubMed ID: 28665894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.